Lataa...
Acute Respiratory Distress Syndrome after Rituximab Infusion
Rituximab, a humanized monoclonal antibody approved for malignant lymphoma, is being increasingly, effectively, and safely used for immune thrombocytopenic purpura (ITP) and other humoral autoimmune disorders. We report the case of a 43-year-old man with ITP refractory to steroids and intravenous im...
Tallennettuna:
| Julkaisussa: | Int J Hematol |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Springer Japan
2005
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7101654/ https://ncbi.nlm.nih.gov/pubmed/16298824 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1532/IJH97.NA0506 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|